PRess releases
SteinCares Strengthens its Onco-Hematology Portfolio with the Introduction of Spectrila® in Brazil
ANVISA approval for the Spectrila® marketing authorization transfer enables SteinCares to ensure uninterrupted access to essential Acute Lymphoblastic Leukemia (ALL) treatment in Brazil. The milestone strengthens SteinCares' onco-hematology portfolio and reinforces...
SteinCares and Shilpa Biologicals Strike into licensing agreement to Expand Access to Biosimilars Across Latin America
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform Collaboration aims to expand patient access to cost-effective treatments and reinforces SteinCares’ leadership in biosimilars...
SteinCares Earns AA Rating from Moody’s, Reflecting Strong Financial Profile, Operational Excellence, and Robust Governance
San Jose, Costa Rica, January 19th, 2026 — SteinCares announced today that Moody’s Investors Service has assigned the company an AA credit rating with Stable outlook, highlighting its solid financial position, resilient business model, and disciplined operational...
SteinCares Expands its Portfolio in Brazil with Monofer®
SteinCares strengthens its role as the regional partner for global pharmaceutical companies seeking to bring innovative therapies to Latin American patients. Through this agreement, the company will continue to expand access to innovative, high-quality, and...
SteinCares Opens New Facility in Costa Rica to Strengthen Access to Specialty Healthcare Across Latin America
The new facility will enable the packaging and distribution of innovative medicines from Costa Rica to the entire Latin American region. This strategic investment reinforces SteinCares’ commitment to sustainable growth and job opportunties for the region. San Jose,...
SteinCares Enters the Mexican Market Through a Strategic Joint Venture with Laboratorios Carnot
SteinCares enters Mexico—one of the most strategic pharmaceutical markets in Latin America—to expand its footprint and accelerate growth across the region. The partnership marks a major milestone in SteinCares’ regional expansion, underscoring its commitment to...
Bio-Thera Solutions and SteinCares Expand Partnership to Commercialize Biosimilars for Treatment of Inflammatory Diseases Across Latin America
This new agreement marks the fourth product in the partnership and introduces a potential cost-effective alternative to one of the world’s top-selling biologics—broadening access to specialty care for patients with chronic inflammatory diseases. The partnership...
Lupin and SteinCares Enter into License and Supply Agreement for Ranibizumab in Latin America
This deal strengthens SteinCares’ leadership in the biosimilar segment across Latin America with this treatment for diverse ophthalmological diseases. The partnership will result in significant cost savings for institutions in the region by providing access to a...
SteinCares and Pharmacosmos Launch Monofer® in Six New Latin American Markets to Address Iron Deficiency
This strategic partnership brings an innovative intravenous iron replacement therapy to Ecuador, the Dominican Republic, Guatemala, Chile, Panama and soon in Costa Rica — offering a safe and effective treatment alternative for patients. The expanded collaboration is a...
SteinCares and Medac Expand Metoject® Access Across Latin America
Strategic alliance drives growth, launching Metoject in Costa Rica, Dominican Republic, Guatemala and Panama, following successful commercialization in Colombia, Chile, and Ecuador. This expanded collaboration highlights SteinCares’ strategic role as a bridge between...
SteinCares is a leader in commercializing and distributing specialty healthcare products in Latin America, including innovative pharmaceuticals, biosimilars and complex generics.
Follow Us on LinkedIn
DISCLAIMER: This website cannot and does not claim to contain any medical advice. The medical or products’ details information is provided for general information and is not a substitute for professional advice and/or information. Please beware that we do not take any responsibility for accessing such information which may not comply with the policies in the country of your origin.
Copyright © 2023 SteinCares. All right reserved.